Psychopharmacologic drugs in chronic pain syndromes
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bonica JJ:The Management of Pain. Malvern, PA: Lea & Febiger, 1994.
World Health Organization:
Russell K, Portenoy RK:Adjuvant analgesics in pain management.In InOxford Textbook of Palliative Medicine. New York: Oxford University Press; 1993: 187–203.
Of importance Jacox A, Carr DB, Payne R,et al.:
Gallagher RM, Woznicki M:Low back pain rehabilitation.In InMedical Psychiatric Practice. Edited by Stoudemire A, Fogel BS, Washington, DC: APA Press; 1993.
Onghena P, Van Houdenhove B:Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies.Pain 1991,49:205–219.
Goodkin K, Guillian CM:Antidepressants for the relief of chronic pain: do they work? Ann Behav Med 1989,11:83–101.
Getto CJ, Sorkness CA, Howell T:Antidepressants and non-malignant pain: a review.J. Pain Symptom Manage 1987,2:9–18. ▸ View thePubMed notation for this reference.
Walker EA, Sullivan MD, Stenchever MA:Use of antidepressants in the management of women with chronic pelvic pain.Obstet Gynecol Clin North Am 1993,20:743–751. ▸ View thePubMed notation for this reference.
France RD:The future of antidepressants: treatment of pain.Psychopathology 1987,20(suppl 1):99–113. ▸ View thePubMed notation for this reference.
Engel G:Psychogenic pain and the pain prone patient.Am J Med 1959,26:899–918. ▸ View thePubMed notation for this reference.
Blumer D, Heilbron M:Chronic pain as a variant of depressive disease: the pain-prone disorder.J Nerv Mental Dis 1982,170:381–406.
Aronoff GM, Evans WO:Evaluation and treatment of chronic pain at the Boston Pain Center.J Clin Psychiatry 1982,43:2–7.
Ventafridder V, Bianchi M, Ripamonty C,et al.:Studies on the effect of antidepressants: drugs on the antinociceptive action of morphine and on plasma morphine in rat and man.Pain 1990,43:155–162. ▸ View thePubMed notation for this reference.
Botney M, Fields HL:Amitriptyline potentiates morphine analgesia by direct action on the central nervous system.Ann Neurol 1983,13:160–164. ▸ View thePubMed notation for this reference.
Max MB, Culnane M, Schafer SC,et al.:Amitriptyline relieves diabetic neuropathic pain in patients with normal and depressed mood.Neurology 1987,37:589–596. ▸ View thePubMed notation for this reference.
Of major importance Max M:Antidepressants as analgesics.In InProgress in Pain Research and Management. Seattle: IASP Press; 1994: 229–246. Up to date review.
Spiegel K, Kalb R, Pasternak GW:Analgesic activity of tricyclics antidepressants.Ann Neurol 1983,13:462–465. ▸ View thePubMed notation for this reference.
Watson CPN, Chipman M, Reed K,et al.:Amitriptylene versus maprotilene in post-herpetic neuralgia: a randomized, double-blind, crossover trial.Pain 1992,48:29–36. ▸ View thePubMed notation for this reference.
Cannon RO, Quyyumi AA, Mincemoyer RN,et al.:Imipramine in patients with chest pain despite normal coronary angiograms.N Engl J Med 1994,330:1411–1417. ▸ View thePubMed notation for this reference.
Marbach J:Orofascial facial pain: theory and phenomenology.J Am Dent Assoc 1996,127:221–229. ▸ View thePubMed notation for this reference.
McQuay HJ, Carroll D, Glynn CJ:Dose response for analgesic effect of amitriptyline in chronic pain.Anesthesia 1993,48:281–285.
Bruera E, Ripamonti C:Adjuvants to opioid analgesics.In InCancer Pain. Edited by Patt RB. New York: Lippincott; 1993: 143–157.
Crewe HK, Lennard MS, Tucker GT,et al.:The effect of selective serotonin reuptake inhibitors on the cytochrome-p450206 (CYP206) activity in human liver microsomes.Br J Clin Pharm 1992,34:262–265.
Hynes MD, Lochner MD, Bemis KG,et al.:Fluoxetine, a selective inhibitor of serotonin uptake, potentiates morphine analgesics without altering its discriminative stimulus properties or affinity for opioid receptors.Life Sci 1985,36:2317–2323. ▸ View thePubMed notation for this reference.
Diamond S, Frietag FG:The use of fluoxetine in the treatment of headache.Clin J Pain 1989,5:200–201. ▸ View thePubMed notation for this reference.
Geller SA:Treatment of fibrositis with fluoxetine.Am J Med 1989,87:594–595. ▸ View thePubMed notation for this reference.
Theesen KA, Marsh WR:Relief of diabetic neuropathy with fluoxetine.DICP 1989,23:572–574. ▸ View thePubMed notation for this reference.
Ventafridda V, Bonezzi C, Caraceni A,et al.:Antidepressants for cancer pain and other painful syndromes with deafferentation component: comparison of amitriptyline and trazodone.Ital J Neuro Sci 1987,8:579–587.
Sindrup SH, Gram LF, Brosen K,et al.:The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms.Pain 1990,42:135–144. ▸ View thePubMed notation for this reference.
Manna V, Bolino F, DiCicco L:Chronic tension type headache, depression and serotonin: therapeutic effects of fluvoxamine and mianserine.Headache 1994,34:44–49. ▸ View thePubMed notation for this reference.
Of major importance Maxmen JS, Ward NG:Psychotropic Drugs: Fast Facts. New York: WW Norton; 1995. Excellent handbook giving detailed information about all aspects of psychotropic drugs, including detailed profiles of pharmacology and tips on clinical use, in a practical and accessible format. It does not deal specifically with pain, however.
Bank J:A comparison study of amitriptylene and fluvoxamine in migraine prophylaxis.Headache 1994, 476–478.
Pramond R, Felt-Hansen PT:Sumatriptan-migraine.In InThe Headache. New York: Raven Press, 1993:329–341.
Wells KB, Golding JM, Burnham MA:Psychiatric disorder in a sample of the general medical population with and without chronic medical conditions.Am J Psychiatry 1988,145:976–981. ▸ View thePubMed notation for this reference.
Depression Guideline Panel:.
Depression Guideline Panel:.
Wells KB, Golding JM, Burnham MA:The functioning and well-being of depressed patients: results from the Medical Outcomes Study.JAMA 1989,262:914–919. ▸ View thePubMed notation for this reference.
Seligman MEP:Helplessness: On Depression, Development, and Death. San Fransisco: WH Freeman; 1975.
Gallagher RM, McCann W, Hughes J,et al.:The Behavioral Medicine Service: an administrative model for biopsychosocial teaching, research and clinical care.Gen Hosp Psychiatry 1990,12:283–295. ▸ View thePubMed notation for this reference.
Gallagher RM, Williams B, Skelly J,et al.:Workers compensation and return-to-work in low back pain.Pain 1995,61:299–307. ▸ View thePubMed notation for this reference.
Couch JR, Diamond S:Status migrainosus: causative and therapeutic aspects.Headache 1983,23:94–101. ▸ View thePubMed notation for this reference.
Lipton RB, Feet-Hansen PT:Neuroleptics.In InThe Headache. New York: Raven Press; 1993: 349–352.
Lechin F, Vander Digs B, Lechin ME,et al.:Pimazide therapy for trigeminal neuralgia.Arch Neurol 1989,9:960–962.
Hakkarainen H:Fluphenazine for tension headache: a double blind study.Headache 1977,17:216–218. ▸ View thePubMed notation for this reference.
Davis JL, Lewis B, Gerich JE,et al.:Peripheral diabetic neuropathy treated with amitriptyline and fluphenazine.JAMA 1977,238:2291–2292. ▸ View thePubMed notation for this reference.
Farber GA, Burks JW:Chlorprothixene therapy for herpes zoster neuralgia.South Med J 1994,67:808–812.
Sigwald J, Bouttier D, Laille F, Taub A:Relief of postherpetic, neuralgia with psychotropic drugs.J Neurosurg 1973,39:235–239. ▸ View thePubMed notation for this reference.
Tek DS, McClellan DS, Olshaker JS,et al.:A prospective double blind study of metoclopramide HCL for the control of migraine in the emergency department.Ann Emerg Med 1990,19:1083–1087. ▸ View thePubMed notation for this reference.
Moore J, Dundee JW:Alterations in response to somatic pain with anesthesia: VII. The effect of nine phenothiazine derivatives.Br J Anaesth 1961,33:422. ▸ View thePubMed notation for this reference.
Head M, Lal H, Puri S,et al.:Enhancement of morphine analgesia after acute and chronic haloperidol.Life Sci 1979,24:2037. ▸ View thePubMed notation for this reference.
Beaver WT, Wallenstein SL, Noude RW,et al.:A comparison of the analgesic effect of methotrimeprazine and morphine in patients with cancer.Clin Pharmacol Ther 1966,7:436–446. ▸ View thePubMed notation for this reference.
Bronwell AW, Rutledge R, Dalton ML:Analgesic effect of methotrimeprazine and meperidine in post operative patients.Ann Surg 1966,32:741–744.
Hoffman BB, Lefkowitz RJ,et al.:Adrenergic receptor antagonists.In InThe Pharmacological Basis of Therapeutics. Edited by Gilman AG, Rall TW, Nies AS, New York: Pergamon Press; 1990: 187–243.
Evans W, Beryner D:A comparison of the analgesic effect of morphine, pentazocine and a mixture of methamphetamine and pentazocine in rats.J New Drugs 1964,4:82–85.
Ivy A, Goetzl F, Burril D:Morphine-dextroamphetamine analgesia.War Med 1984,6:67–77.
Forrest W, Brown B, Brown C,et al.:Dextroamphetamine with morphine for the treatment of post-operative pain.N Engl J Med 1977,296:712–715. ▸ View thePubMed notation for this reference.
Roland R, Griffiths AND, Munford GK:Caffeine.In InPsychopharmacology, the Fourth Generation in Progress. New York: Raven Press; 1955: 1699–1713.
Food and Drug Administration Advisory Review Panel on OTC:Sedative, tranquilizers and sleep aid drug products (40FR57292).Fed Reg 1975,42:35482–35485.
Over the counter drugs.:Establishment of monograph for OTC internal analgesic, antipyretic and antirheumatic products.Fed Reg 1977,42:35439–35487.
Cocaine Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995: 1685–1697.
Foley K, Macaluso C:Adjuvant analgesic drugs in cancer pain management.In InEvaluation and Treatment of Chronic Pain. Baltimore: Williams and Wilkins; 1992: 340–348.
Singh PN, Sharma P, Gupta PK, Pandey K:Clinical evaluation of diazepam for relief of post operative pain.Br J Anaesth 1981,53:831–836. ▸ View thePubMed notation for this reference.
Miller R,et al.:Midazolam as an adjunct to meperidine analgesia for postoperative pain.Clin J Pain 1986,2:37–43.
King SA, Strain JJ:Benzodiazepine use by chronic pain patients.Clin J Pain 1990,6:143–147. ▸ View thePubMed notation for this reference.
Fernandez F, Adams F, Holmes VF:Analgesic effect of alprazolam in patients with chronic, organic pain.J Clin Psychopharmacol 1987,7:167–169. ▸ View thePubMed notation for this reference.
Of importance Amoi S:The Pain Handbook. St. Louis: Mosby-Year Book; 1995. A practical pocket guide to pain management.
Loeser JD, Ward AA, White LE:Chronic deferentation of human spinal cord neurons.J Neurosurg 1968,29:48–50. ▸ View thePubMed notation for this reference.
Mokha SS, McMillan JA, Iggo A:Descending influences on spinal nociceptive neurons from locus coeruleus: action, pathway, neurotransmitters, and mechanisms.In InAdvances in Pain Research and Therapy. Edited by Bonica JJ, Lindblan V, Iggo A. New York: Raven Press, 1983: 387–392.
Mason P, Skinner K, Cho HJ,et al.:Anatomical evidence for GABAergic control of physiologically identified off-cells in rostral ventromedial medulla.In InProceedings of the VI World Congress on Pain. Edited by Bon MR, Charlton JE, Wolff CJ. New York: Elsevier; 1991: 331–335.
Mayer TG, Gatchel RJ, Mayer H,et al.:A prospective two-year study of functional restoration in industrial low back pain.JAMA 1987,258:1763–1768. ▸ View thePubMed notation for this reference.
Hazard RG, Genwich JW, Kalish SM,et al.:Functional restoration with behavioral support: a one year prospective study of patients with chronic low back pain.Spine 1989,14:157–161. ▸ View thePubMed notation for this reference.
Washold BE, Wilson WP:Central pain and irritable midbrain.In InPain and Suffering. Edited by Crue B. Springfield, IL: Charles C. Thomas; 1970: 95.
Nysfrom B, Hagbarth KE:Miloelectrode recording from transmitter nerves in amputees with phantom limb pain.Neurosci Lett 1981.27:211–216. ▸ View thePubMed notation for this reference.
Tasker RR, Dostrovsky JO:Deafferentation and central pain.In InTextbook of Pain. Edited by Wall PD, Melzack R. Edinburgh: Churchill-Livingstone; 1989: 154–180.
Englander RN, Johnson RSN, Brickley JJ, Nanna GR:Effects of antiepileptic drugs on thalamocortical excitability.Neurology 1977,27:1134–1139. ▸ View thePubMed notation for this reference.
Kaplan H, Sadock BJ:Synopsis of Psychiatry. New York: Williams and Wilkins; 1994.
Swerdlow M:Anticonvulsant drugs and chornic pain: management of cancer pain.Clin Neuropharmacol 1984,7:51–82. ▸ View thePubMed notation for this reference.
Dunsker SB, Mayfield FN:Carbamazepine in the treatment of flashing pain syndrome.J Neurosurg 1976,45:49–51.
Nicol CF:A four year double blind trial of carbamazepine in facial pain.Headache 1969,9: 54–57. ▸ View thePubMed notation for this reference.
Elliot F, Little A, Milbrandt W:Carbamazepine for phantom limb phenomena.N Engl J Med 1976,295: 678.
Canton FK:Phenytoin treatment of thalamic pain.BMJ 1972,2: 590. ▸ View thePubMed notation for this reference.
Chadda VS, Mathur MS:Double blind study of the effect of diphenylhydantoin sodium in diabetic neuropathy.J Assoc Physicians India 1978,26: 403–406. ▸ View thePubMed notation for this reference.
Ellenberg M:Treatment of diabetic neuropathy with diphenylhydantoin.N Y State J Med 1976,68: 678.
Bubowsky SL:Geriatric neuropsychopharmacology.In InAPA Textbook of Geriatric and Neuropsychiatry Coffey CE, Cummings JL, eds. Washington, DC: American Psychiatric Press; 1994: 596–631.
Caccia MR:Clonazepam in facial neuralgia and cluster headache: clinical and electrophysiological study.Eur J Neurol 1975,13: 560–563.
Raftery H.:The management of postherptic pain using sodium valproate and amitriptyline.J Irish Med Assoc 1959,72: 399–407.
Peiris JB, Perera GLS, Devendra SV:Sodium valproate in trigeminal neuralgia.Med J Aust 1980,2: 278. ▸ View thePubMed notation for this reference.
Bruera E, Navigante A, Barugel M,et al.:Treatment of pain and other symptoms in cancer patients: patterns in a North American and South American hospital.J Pain Symptom Management 1990,5: 78.
Monks R:Psychotropic drugs.In InTextbook of Pain. Edited by Wall PD, Melzack R. Edinburgh: Churchill-Livingstone; 1994; 963–989.
Goa KL, Sorkin EM:Gabapentin: a review of its pharmacological properties and clinical potential in epilepsy.Drugs 1993,3: 46.
Mellick GA, Mellicy LB, Mellick LB:Gabapentin in the management of reflex sympathetic dystrophy.J Pain Symptom Manage 1995,10: 265–266. ▸ View thePubMed notation for this reference.
Rosner H, Rubin L, Kestenbaum H:Gabapentin adjunctive therapy in neuropathic pain states.Clin J Pain 1996,12: 56–58. ▸ View thePubMed notation for this reference.
Andrew J, Chadwick D, Bates D:Gabapentin in partial epilepsy.Lancet 1990,335: 1114–1117. ▸ View thePubMed notation for this reference.
Mellick GA, Seng ML:The use of gabapentin in the treatment of reflex sympathetic dystrophy and a phobic disorder.Am J Pain Management 1995,5: 7–9.
Leiderman DB:Gabapentin as add-on therapy for refractory partial epilepsy: results of five placebo-controlled trials.Epilepsia 1994,35(Suppl 5): S74-S76. ▸ View thePubMed notation for this reference.
Ekbom K:Lithium for cluster headache: review of the literature and preliminary results of long term treatment.Headache 1981,21: 132–139. ▸ View thePubMed notation for this reference.
Kudrow L:Lithium prophylaxis for chronic cluster headache.Headache 1977,17: 15–18. ▸ View thePubMed notation for this reference.